Research location
Reisterstown
Maryland, United States
Advertisement
Research activity in Reisterstown
Maryland, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 11 trials and 11 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Reisterstown
11 linked trials · page 1 of 1A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal InsulinNCT02131272 · 2014-06-11 · 1 site observation
TERMINATED
INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With MacroalbuminuriaNCT01398423 · 2011-06-01 · 1 site observation
COMPLETED
The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)NCT01106625 · 2010-05-01 · 1 site observation
COMPLETED
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesNCT01076647 · 2010-03-01 · 1 site observation
COMPLETED
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesNCT00982644 · 2009-09-01 · 1 site observation
COMPLETED
Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care SettingNCT01013948 · 2009-02-01 · 1 site observation
COMPLETED
A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood PressureNCT00791258 · 2008-11-01 · 1 site observation
COMPLETED
Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive PatientsNCT00734630 · 2008-08-01 · 1 site observation
COMPLETED
DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant HypertensionNCT00353574 · 2006-09-01 · 1 site observation
TERMINATED
DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant HypertensionNCT00330369 · 2006-06-01 · 1 site observation
COMPLETED
The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)NCT00279201 · 2005-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.